Lion Licenses SRS to Incyte | GenomeWeb

NEW YORK, April 2 - Lion Bioscience has licensed its SRS bioinformatics platform to Incyte Genomics for three years, the German company said on Tuesday.

Financial terms of the deal were not disclosed, but Lion said it expects to pocket annual license fees and royalties from Incyte as well as from those Incyte customers that use the SRS-based software platform.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.